Insmed Inc. buy Rothschild & Co Redburn
Start price
04.12.25
/
50%
€179.00
Target price
04.12.26
€225.50
Performance (%)
-30.73%
Price
06.03.26
€120.00
Summary
This prediction is currently active. The BUY prediction by Rothschild___Co_Redb for Insmed Inc. is performing very badly with a performance of -30.73%. This prediction currently runs until 04.12.26. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -4.000% | -4.000% |
| iShares Core DAX® | -3,52 % | -4,99 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % |
| iShares S&P 500 | -0,82 % | -0,04 % |
Comments by Rothschild___Co_Redb for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $263.00 price target on the stock.
Ratings data for INSM provided by MarketBeat